UPTAKE研究:新冠疫苗接种试验招募的未来启示
该研究通过在英国范围匿名横断面在线调查,分析公众对参与新冠疫苗接种试验的意愿及相关人口学与地理因素。4884名参与者中41.4%有意参与,BAME人群、农村和小城镇居民及70岁以上者参与意愿较低,提示需针对这些群体加强招募宣传。
要点
- BAME人群参与疫苗试验意愿显著较低(OR=0.43)。
- 40-49岁和50-59岁年龄组参与意愿较高(OR=1.88和1.46)。
- 农村和小城镇居民参与意愿较低(OR=0.66和0.54)。
核心结论
- 为使疫苗接种结果可推广至全人群,需加大力度吸引多样化参与者。
- 公共卫生运动需针对老年人、BAME社区和受教育程度较低的农村人群提高试验招募率。
研究设计与样本
- 匿名横断面在线调查,在英国范围发放。
- 共4884名参与者,其中9.44%为BAME。
- 统计分析分六个阶段进行,采用多分类逻辑回归模型检查影响疫苗接种意愿的人口学和地理因素。
主要发现
- 2020名(41.4%)受访者有兴趣参与疫苗试验;27.6%不感兴趣,31.1%不确定。
- 最感兴趣的群体:男性(OR=1.29)、毕业生(OR=1.28)、40-49岁(OR=1.88)和50-59岁(OR=1.46)以及无健康问题者(OR=1.06)。
- 最不感兴趣的群体:BAME(OR=0.43)、来自村庄和小城镇者(OR分别为0.66和0.54)以及70岁及以上者(OR=1.11)。
关键数值与推荐
- BAME参与意愿OR=0.43。
- 村庄和小城镇居民参与意愿OR=0.66和0.54。
- 70岁及以上者OR=1.11。
- 男性OR=1.29,毕业生OR=1.28,40-49岁OR=1.88,50-59岁OR=1.46,无健康问题者OR=1.06。
临床怎么用
- 试验招募应针对性覆盖BAME社区、农村和小城镇居民及70岁以上老年人。
- 公共卫生宣传需针对上述群体设计,以提高试验参与率。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Developing a safe and effective vaccine will be the principal way of controlling the COVID-19 pandemic. However, current COVID-19 vaccination trials are not adequately representing a diverse participant population in terms of age, ethnicity and comorbidities. Achieving the representative recruitment targets that are adequately powered to the study remains one of the greatest challenges in clinical trial management. To ensure accuracy and generalisability of the safety and efficacy conclusions generated by clinical trials, it is crucial to recruit patient cohorts as representative as possible of the future target population. Missing these targets can lead to reduced validity of the study results and can often slow down drug development leading to costly delays. OBJECTIVE: This study explores the key factors related to perceptions and participation in vaccination trials. METHODS: This study involved an anonymous cross-sectional online survey circulated across the UK. Statistical analysis was done in six phases. Multi-nominal logistic models examined demographic and geographic factors that may impact vaccine uptake. RESULTS: The survey had 4884 participants of which 9.44% were Black Asian Minority Ethnic (BAME). Overall, 2020 (41.4%) respondents were interested in participating in vaccine trials; 27.6% of the respondents were not interested and 31.1% were unsure. The most interested groups were male (OR = 1.29), graduates (OR = 1.28), the 40-49 and 50-59 age groups (OR = 1.88 and OR = 1.46 respectively) and those with no health issues (OR = 1.06). The least interested groups were BAME (OR = 0.43), those from villages and small towns (OR = 0.66 and 0.54 respectively) and those aged 70 and above (OR = 1.11). CONCLUSIONS: In order to have a vaccination that is generalisable to the entire population, greater work needs to be done in engaging a diverse cohort of participants. Public health campaigns need to be targeted in improving trial recruitment rates for the elderly, BAME community and the less educated rural population.
引用
- Sethi S, Kumar A, Mandal A, et al. The UPTAKE study: implications for the future of COVID-19 vaccination trial recruitment in UK and beyond. Trials. 2021. PMID: 33879208. doi:10.1186/s13063-021-05250-4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。